Articles written by: Williams Rhonda

Tenax Therapeutics Inc. (TENX)’s Financial Results Comparing With TrovaGene Inc. (NASDAQ:TROV)

Tenax Therapeutics Inc. (NASDAQ:TENX) and TrovaGene Inc. (NASDAQ:TROV), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation of the two firms. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings […]

Sutro Biopharma Inc. (STRO) and Checkpoint Therapeutics Inc. (NASDAQ:CKPT) Comparing side by side

Both Sutro Biopharma Inc. (NASDAQ:STRO) and Checkpoint Therapeutics Inc. (NASDAQ:CKPT) are each other’s competitor in the Biotechnology industry. Thus the contrast of their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sutro Biopharma Inc. […]

PPDAI Group Inc. (PPDF) and CNFinance Holdings Limited (NYSE:CNF) Contrasting side by side

PPDAI Group Inc. (NYSE:PPDF) and CNFinance Holdings Limited (NYSE:CNF) compete with each other in the Credit Services sector. We will analyze and contrast their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PPDAI Group […]

Xencor Inc. (XNCR)’s Financial Results Comparing With Ionis Pharmaceuticals Inc. (NASDAQ:IONS)

Xencor Inc. (NASDAQ:XNCR) and Ionis Pharmaceuticals Inc. (NASDAQ:IONS), both competing one another are Biotechnology companies. We will compare their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Xencor Inc. 36 11.57 N/A 0.65 68.14 […]

GAMCO Natural Resources Gold & Income Trust (GNT) and Firsthand Technology Value Fund Inc. (NASDAQ:SVVC) Comparison side by side

Both GAMCO Natural Resources Gold & Income Trust (NYSE:GNT) and Firsthand Technology Value Fund Inc. (NASDAQ:SVVC) compete on a level playing field in the Asset Management industry. We will evaluate their performance with regards to dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Earnings and Valuation Gross Revenue […]

Comparison of Atrion Corporation (ATRI) and Valeritas Holdings Inc. (NASDAQ:VLRX)

Both Atrion Corporation (NASDAQ:ATRI) and Valeritas Holdings Inc. (NASDAQ:VLRX) are Medical Instruments & Supplies companies, competing one another. We will contrast their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Atrion Corporation 832 9.44 […]

Franklin Electric Co. Inc. (FELE) and Atkore International Group Inc. (NYSE:ATKR) Comparing side by side

Franklin Electric Co. Inc. (NASDAQ:FELE) and Atkore International Group Inc. (NYSE:ATKR) compete with each other in the Industrial Electrical Equipment sector. We will analyze and compare their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Hemispherx Biopharma Inc. (HEB)’s Financial Results Comparing With Replimune Group Inc. (NASDAQ:REPL)

Both Hemispherx Biopharma Inc. (NYSEAMERICAN:HEB) and Replimune Group Inc. (NASDAQ:REPL) are each other’s competitor in the Biotechnology industry. Thus the compare of their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hemispherx Biopharma Inc. […]